The {pharmaceutical sector is increasingly exploring innovative treatment strategies for obesity , and the emergence of semaglutide 10mg injectables represents the development . Doctors are beginning to assess the potential benefits and drawbacks associated with this increased strength formulation , notably in contrast with existing standard semagl